As previously described for CKD patients, increased plasma PTH and hyperphosphatemia have been found to be a frequent and deleterious condition associated with the progression of mineral bone disease and an increased risk for all-cause mortality [190,191,192]. This evidence concerns the gene PTH and hyperphosphatemia.